Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-08-20 | Amended | $15,955,000 | $3,455,000 | Equity Only | 06b | SEC link |
| 2024-08-07 | New | $12,500,000 | $12,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Kyle Lefkoff | Director |
| William S. Marshall | Director |
| John S. Orwin | Director |
| David S. Snitman | Director |
| Nicholas Traggis | Director, Executive |